Doctor of Philosophy (PhD), Copenhagen University. Membership of the Royal College of Physicians (MRCP), London. Bachelor of Medicine and Bachelor of Surgery (MBBS), Imperial College. Master of Arts (MA), Medicine, Cambridge University

Christopher is responsible for the clinical development of SoftOx Inhaled Solution (SIS). He is a qualified medical doctor and researcher and has more than 15 years’ experience in the Life Science Industry, from small biotech to large pharma. Christopher has worked in medical affairs and clinical development functions across a range of inflammatory and immunological therapeutic indications, involving small molecule and biological products. He has extensive knowledge regarding the planning and conduct of clinical trials, and the commercial and reimbursement requirements for successful launch.

Christopher has additional interests in risk analysis, translational medicine, and real-world evidence (RWE).